CompletedPhase 3NCT01715207

Comparison of Aliskiren vs Negative Controls on Aortic Stiffness in Patients With MFS

Studying Marfan syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Samsung Medical Center
Principal Investigator
Duk-Kyung Kim, PhD MD
Samsung Medical Center
Intervention
Aliskiren(drug)
Enrollment
30 enrolled
Eligibility
14-55 years · All sexes
Timeline
20102014

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01715207 on ClinicalTrials.gov

Other trials for Marfan syndrome

Additional recruiting or active studies for the same condition.

See all trials for Marfan syndrome

← Back to all trials